BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

OAKTREE CAPITAL MANAGEMENT LP's Holding History (CIK: 0000949509)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,550,000 Value ($000) $2,872 Avg Close — Range —
Q3 2025
Shares 10,757,000 Value ($000) $10,631 Avg Close — Range —
Q2 2025
Shares 18,056,000 Value ($000) $16,900 Avg Close — Range —
Q1 2025
Shares 14,135,000 Value ($000) $12,743 Avg Close — Range —
Q4 2024
Shares 3,798,000 Value ($000) $3,259 Avg Close — Range —
Q3 2024
Shares 2,382,000 Value ($000) $2,001 Avg Close — Range —
Q2 2024
Shares 3,818,000 Value ($000) $3,042 Avg Close — Range —
Q1 2024
Shares 3,529,000 Value ($000) $2,891 Avg Close — Range —
Q4 2023
Shares 5,027,000 Value ($000) $4,283 Avg Close — Range —
Q3 2023
Shares 6,485,000 Value ($000) $4,864 Avg Close — Range —
Q2 2023
Shares 7,287,000 Value ($000) $4,510 Avg Close — Range —
Q1 2023
Shares 3,984,000 Value ($000) $2,579 Avg Close — Range —